Effect of Denosumab on Fasting Glucose in Women With Diabetes or Prediabetes From the FREEDOM Trial

ConclusionsDMAb did not affect FSG in postmenopausal osteoporotic women with prediabetes or diabetes. There was evidence of modest FSG lowering with DMAb in those with diabetes who were not on ADM. It remains to be determined whether blockade of RANKL has a clinically important effect on glucose metabolism.

Source: Diabetes/Metabolism Research and Reviews - January 1, 2018 Category: Endocrinology Authors: Nicola Napoli, Nicola Pannacciulli, Eric Vittinghoff, Daria Crittenden, Jang Yun, Andrea Wang, Rachel Wagman, Ann V. Schwartz Tags: RESEARCH ARTICLE Source Type: research